Sinusitis Board decisions

The Board granted service connection for chronic sinusitis and denied earlier effective dates for the awards of service connection for lumbosacral strain, tinnitus, asthma, rhinitis, and a compensable disability rating for rhinitis.

The Board denied an increased rating for chronic sinusitis and remanded claims for service connection for dermatitis, infertility, and a low back condition.

The Board granted service connection for obstructive sleep apnea and gastrointestinal reflux disease, but denied service connection for irritable bowel syndrome, epistaxis, sinusitis, diabetic right foot with fifth toe removal, and diabetic left foot with fifth toe removal. The decision also denied a compensable rating for migraine headaches.

The Board denied the veteran's claims for increased ratings and service connection, remanding some issues for further development.

The Board dismissed the claim for service connection for sinusitis and denied claims for earlier effective dates, increased ratings, and service connection for various conditions. Some issues were remanded for further development.

The Board denied a compensable rating for allergic rhinitis and remanded the issue of service connection for sinusitis.

The Board denied the veteran's claims for a rating in excess of 70 percent for PTSD and service connection for sinusitis, finding that the evidence did not support a higher disability rating or a current diagnosis of sinusitis.

The Board denied the Veteran's claims for increased ratings for allergic rhinitis and sinusitis, as the evidence did not support a compensable disability evaluation.

The Board remands the claims for an initial compensable rating for tension headaches, service connection for a skin condition, asthma, a disability other than asthma manifested by difficulty breathing through the nose (sinusitis), obstructive sleep apnea (OSA), and a disability manifested by fatigue due to pre-decisional duty to assist errors.

The Board remands the claims for service connection for rhinitis, sinusitis, headaches, and bilateral hearing loss to obtain additional evidence through a new VA examination.

The Board granted an initial 10 percent disability rating for rhinitis and sinusitis, but remanded the claim for a right knee disability.

The Board denied service connection for anxiety and a compensable initial disability rating for allergic rhinitis, finding that the Veteran's symptoms were already encompassed by his service-connected PTSD with depressive disorder.

The Board granted an effective date of August 10, 2022, for service connection for allergic rhinitis with polyps based on the passage of the PACT Act.

The Board denied service connection for sinusitis as there is no current disability, and the Veteran's subjective reports are not related to an undiagnosed illness or MUCMI. The claims for allergic rhinitis and GERD were remanded for further development.

The Board granted an increased rating of 10 percent for sinusitis, as the Veteran's symptoms more closely approximated one to two incapacitating episodes per year requiring treatment with antibiotics.

The Board granted service connection for sinusitis and dismissed the appeal for a rating higher than 30 percent for chronic right eye iritis. Other claims for service connection were denied.

The Veteran's service-connected PTSD with major depressive disorder (MDD) and generalized anxiety disorder was granted a 70 percent rating effective January 14, 2022, and entitlement to TDIU and SMC at the housebound rate were also granted on that date.

The Board denied the Veteran's claim for an initial compensable rating for rhinitis as there was no evidence of nasal polyps or greater than 50 percent obstruction on both sides, which are required for a compensable rating.

The Board granted an effective date of August 5, 2021, for the grant of service connection for sinusitis and denied an earlier effective date for a 30 percent evaluation for rhinitis.

The Board denied the Veteran's claim for an evaluation in excess of 0 percent for allergic rhinitis as the evidence did not support a higher rating.